A cut-off of 200 ng/ml is associated with high specificity for HCC which should alleviate bias, as samples with AFP greater than 200 ng/ml would likely have been diagnosed by traditional methods therefore, this cut-off is more likely to be reproducible in a real-world scenario. This evidence concerns the gene AFP and hepatocellular carcinoma.